
Neurocysticercosis Among Patients With Cerebral Gliomas
Oscar H. Del Brutto, MD;
Pablo R. Castillo, MD;
Iván X. Mena, MD;
Amado X. Freire, MD, MPH
Arch Neurol. 1997;54(9):1125-1128.
Abstract
 |  |
Background Parasites have been implicated in the pathogenesis of human cancer. Anecdotal reports have suggested an association between neurocysticercosis and brain tumors.
Objective To determine whether neurocysticercosis is a risk factor for cerebral glioma.
Design Case-control study.
Setting A university general hospital and a cancer referral center.
Patients Forty-three consecutive patients with a cerebral glioma and 172 controls matched for age, sex, and socioeconomic status.
Methods We determined the ratio between the frequency of neurocysticercosis in patients with a cerebral glioma and in matched controls. We also evaluated differences in the characteristics of the patients and in the histological type of the neoplasm among case patients with and without neurocysticercosis. In addition, we noted relationships between the location of the cerebral glioma and that of parasitic lesions.
Results Eight (16.8%) of 43 patients with a glioma and 5 (2.9%) of 172 controls had neurocysticercosis (P<.001). The odds ratio for this association was 7.63 (95% confidence interval, 2.03-31.09). Patients with glioma and neurocysticercosis were older than those without neurocysticercosis (mean [±SD] age, 62.75±18.34 years vs 44.69±14.04 years; P=.02). Glioblastoma multiforme was more frequent among case patients with neurocysticercosis than among those without neurocysticercosis (87.5% vs 48.6%); however, this difference was not statistically significant (P=.24). Six of the 8 patients with neurocysticercosis and a cerebral glioma had calcified parasitic lesions within and around the tumor.
Conclusions Results from this study suggest that neurocysticercosis is a risk factor for cerebral glioma. The intense astrocytic gliosis that surrounds calcified cysticerci, together with the suppression of the cellular immune response induced by cysticerci, may contribute to the development of malignant glial cells in patients with neurocysticercosis.
Author Affiliations
From the Department of Neurology, Luis Vernaza Hospital (Drs Del Brutto and Castillo), and the Neuro-Oncology Service, Instituto Oncológico Nacional (Drs Mena and Freire), Guayaquil, Ecuador.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Is neurocysticercosis a risk factor in coexistent intracranial disease? An MRI based study
Azad et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:359-361.
ABSTRACT
| FULL TEXT
Infection of rats with Taenia taeniformis metacestodes increases hepatic CYP450, induces the activity of CYP1A1, CYP2B1 and COH isoforms and increases the genotoxicity of the procarcinogens benzo[a]pyrene, cyclophosphamide and aflatoxin B1
Montero et al.
Mutagenesis 2003;18:211-216.
ABSTRACT
| FULL TEXT
Increased translocation frequency of chromosomes 7, 11 and 14 in lymphocytes from patients with neurocysticercosis
Herrera et al.
Mutagenesis 2001;16:495-497.
ABSTRACT
| FULL TEXT
|